Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer.

Mazieres J, He B, You L, Xu Z, Lee AY, Mikami I, Reguart N, Rosell R, McCormick F, Jablons DM.

Cancer Res. 2004 Jul 15;64(14):4717-20.

2.

Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.

Taniguchi H, Yamamoto H, Hirata T, Miyamoto N, Oki M, Nosho K, Adachi Y, Endo T, Imai K, Shinomura Y.

Oncogene. 2005 Nov 24;24(53):7946-52.

PMID:
16007117
3.

Wnt signaling activation and WIF-1 silencing in nasopharyngeal cancer cell lines.

Lin YC, You L, Xu Z, He B, Mikami I, Thung E, Chou J, Kuchenbecker K, Kim J, Raz D, Yang CT, Chen JK, Jablons DM.

Biochem Biophys Res Commun. 2006 Mar 10;341(2):635-40. Epub 2006 Jan 17.

PMID:
16427602
4.

Suppression of Wnt signaling by the miR-29 family is mediated by demethylation of WIF-1 in non-small-cell lung cancer.

Tan M, Wu J, Cai Y.

Biochem Biophys Res Commun. 2013 Sep 6;438(4):673-9. doi: 10.1016/j.bbrc.2013.07.123. Epub 2013 Aug 9.

PMID:
23939044
5.

Procaine and procainamide inhibit the Wnt canonical pathway by promoter demethylation of WIF-1 in lung cancer cells.

Gao Z, Xu Z, Hung MS, Lin YC, Wang T, Gong M, Zhi X, Jablons DM, You L.

Oncol Rep. 2009 Dec;22(6):1479-84.

PMID:
19885602
6.

Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.

Urakami S, Shiina H, Enokida H, Kawakami T, Tokizane T, Ogishima T, Tanaka Y, Li LC, Ribeiro-Filho LA, Terashima M, Kikuno N, Adachi H, Yoneda T, Kishi H, Shigeno K, Konety BR, Igawa M, Dahiya R.

Clin Cancer Res. 2006 Jan 15;12(2):383-91.

7.

Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells.

Gao Z, Xu Z, Hung MS, Lin YC, Wang T, Gong M, Zhi X, Jablon DM, You L.

Anticancer Res. 2009 Jun;29(6):2025-30.

8.

Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma.

Batra S, Shi Y, Kuchenbecker KM, He B, Reguart N, Mikami I, You L, Xu Z, Lin YC, Clément G, Jablons DM.

Biochem Biophys Res Commun. 2006 Apr 21;342(4):1228-32. Epub 2006 Feb 24.

PMID:
16516163
9.

Promoter hypermethylation of Wnt inhibitory factor-1 in patients with lung cancer: A systematic meta-analysis.

Zheng Y, Li X, Jiang Y, Xu Y, Song B, Zhou Q, Liang X, Yang X.

Medicine (Baltimore). 2016 Dec;95(49):e5433. Review.

10.
11.

WIF-1 promoter region hypermethylation as an adjuvant diagnostic marker for non-small cell lung cancer-related malignant pleural effusions.

Yang TM, Leu SW, Li JM, Hung MS, Lin CH, Lin YC, Huang TJ, Tsai YH, Yang CT.

J Cancer Res Clin Oncol. 2009 Jul;135(7):919-24. doi: 10.1007/s00432-008-0527-7. Epub 2008 Dec 16.

PMID:
19085002
12.

Transcriptional regulation of Wnt inhibitory factor-1 by Miz-1/c-Myc.

Licchesi JD, Van Neste L, Tiwari VK, Cope L, Lin X, Baylin SB, Herman JG.

Oncogene. 2010 Nov 4;29(44):5923-34. doi: 10.1038/onc.2010.322. Epub 2010 Aug 9.

13.

Norcantharidin inhibits Wnt signal pathway via promoter demethylation of WIF-1 in human non-small cell lung cancer.

Xie J, Zhang Y, Hu X, Lv R, Xiao D, Jiang L, Bao Q.

Med Oncol. 2015 May;32(5):145. doi: 10.1007/s12032-015-0592-0. Epub 2015 Mar 27.

PMID:
25814287
14.

Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer.

Ai L, Tao Q, Zhong S, Fields CR, Kim WJ, Lee MW, Cui Y, Brown KD, Robertson KD.

Carcinogenesis. 2006 Jul;27(7):1341-8. Epub 2006 Feb 25.

PMID:
16501252
15.

Expression and aberrant promoter methylation of Wnt inhibitory factor-1 in human astrocytomas.

Yang Z, Wang Y, Fang J, Chen F, Liu J, Wu J, Wang Y.

J Exp Clin Cancer Res. 2010 Mar 24;29:26. doi: 10.1186/1756-9966-29-26.

16.

Loss of WIF-1 and Wnt5a expression is related to aggressiveness of sporadic breast cancer in Tunisian patients.

Trifa F, Karray-Chouayekh S, Jmal E, Jmaa ZB, Khabir A, Sellami-Boudawara T, Frikha M, Daoud J, Mokdad-Gargouri R.

Tumour Biol. 2013 Jun;34(3):1625-33. doi: 10.1007/s13277-013-0694-2. Epub 2013 Feb 16.

PMID:
23417837
17.

Downregulation of WIF-1 by hypermethylation in astrocytomas.

Yang Z, Wang Y, Fang J, Chen F, Liu J, Wu J, Wang Y, Song T, Zeng F, Rao Y.

Acta Biochim Biophys Sin (Shanghai). 2010 Jun 15;42(6):418-25.

18.

Aberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesothelioma.

Kohno H, Amatya VJ, Takeshima Y, Kushitani K, Hattori N, Kohno N, Inai K.

Oncol Rep. 2010 Aug;24(2):423-31.

PMID:
20596629
19.

Cloning and characterization of the promoter of human Wnt inhibitory factor-1.

Reguart N, He B, Xu Z, You L, Lee AY, Mazieres J, Mikami I, Batra S, Rosell R, McCormick F, Jablons DM.

Biochem Biophys Res Commun. 2004 Oct 8;323(1):229-34.

PMID:
15351726
20.

Wnt inhibitory factor-1 gene transfer inhibits melanoma cell growth.

Lin YC, You L, Xu Z, He B, Yang CT, Chen JK, Mikami I, Clément G, Shi Y, Kuchenbecker K, Okamoto J, Kashani-Sabet M, Jablons DM.

Hum Gene Ther. 2007 Apr;18(4):379-86.

PMID:
17472570

Supplemental Content

Support Center